Allogene exec sells 29,697 shares at $2.12
Allogene Therapeutics, Inc. (ALLO) reported that officer Douglas Earl Martin, SVP and General Counsel, sold 29,697 shares of common stock on August 21, 2026 at $2.12 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Allogene Therapeutics, Inc. (ALLO) reported that officer Douglas Earl Martin, SVP and General Counsel, sold 29,697 shares of common stock on August 21, 2026 at $2.12 per share. The shares were sold to cover tax withholding on vesting RSUs under a mandated "sell to cover" arrangement, so the trade was not discretionary. After this and related adjustments, including forfeiture of performance RSUs and prior ESPP purchases, he directly holds 488,267 shares of Allogene common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2, F3 | 29,697 | $2.12 | $63K |
Footnotes (3)
- F1. Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- F2. Reflects forfeiture of 54,479 shares subject to performance RSUs granted to the Reporting Person on August 14, 2023.
- F3. Includes 7,495 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.
Key Figures
Key Terms
restricted stock units financial
sell to cover financial
performance RSUs financial
employee stock purchase program financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ALLO report for Douglas Earl Martin on August 21, 2026?
Was the August 21, 2026 sale by ALLO executive Douglas Earl Martin a discretionary trade?
What additional equity changes for Douglas Earl Martin are noted in the ALLO Form 4 footnotes?
Was the ALLO insider transaction reported as under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.